We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
-1.37%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$196M
AUM Growth
-$3.16M
Cap. Flow
+$648K
Cap. Flow %
0.33%
Top 10 Hldgs %
25.13%
Holding
97
New
–
Increased
34
Reduced
26
Closed
2

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$2.12M
2
PG icon
Procter & Gamble
PG
+$434K
3
IBB icon
iShares Biotechnology ETF
IBB
+$394K
4
XOM icon
ExxonMobil
XOM
+$342K
5
GE icon
GE Aerospace
GE
+$326K

Top Sells

Rank Stock Value
1
WFC icon
Wells Fargo
WFC
+$2.87M
2
ABBV icon
AbbVie
ABBV
+$426K
3
UNP icon
Union Pacific
UNP
+$351K
4
BBH icon
VanEck Biotech ETF
BBH
+$315K
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$298K

Sector Composition

Rank Sector Weight
1 Technology 14.47%
2 Industrials 14.39%
3 Healthcare 11.95%
4 Financials 11.2%
5 Consumer Staples 9.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.99T
$6.55M 3.34%
71,759
-725
-1% -$66.3K
INTC icon
2
Intel
INTC
$488B
$5.68M 2.89%
109,069
-2,120
-2% -$101K
CSCO icon
3
Cisco
CSCO
$436B
$5.55M 2.83%
129,474
-3,233
-2% -$137K
MA icon
4
Mastercard
MA
$484B
$5.04M 2.57%
28,802
-1,385
-5% -$237K
AAPL icon
5
Apple
AAPL
$4.8T
$4.52M 2.3%
107,720
-1,800
-2% -$77.5K
MMM icon
6
3M
MMM
$83B
$4.49M 2.29%
24,482
+66
+0.3% +$13.1K
ABBV icon
7
AbbVie
ABBV
$448B
$4.41M 2.25%
46,564
-3,875
-8% -$426K
IEMG icon
8
iShares Core MSCI Emerging Markets ETF
IEMG
$149B
$4.4M 2.24%
75,394
+1,786
+2% +$106K
IJR icon
9
iShares Core S&P Small-Cap ETF
IJR
$109B
$4.38M 2.23%
56,845
+860
+2% +$66.9K
XYL icon
10
Xylem
XYL
$28.7B
$4.29M 2.19%
55,812
-2,500
-4% -$185K
IVV icon
11
iShares Core S&P 500 ETF
IVV
$879B
$4.28M 2.18%
16,136
+756
+5% +$208K
WMT icon
12
Walmart Inc
WMT
$893B
$4.21M 2.15%
141,993
+4,395
+3% +$141K
FAST icon
13
Fastenal
FAST
$51.4B
$4.08M 2.08%
298,672
-2,920
-1% -$40.2K
ACN icon
14
Accenture
ACN
$88.6B
$4.04M 2.06%
26,301
-455
-2% -$72.1K
BRK.B icon
15
Berkshire Hathaway Class B
BRK.B
$1.06T
$4.01M 2.04%
20,093
-1,451
-7% -$298K
CHRW icon
16
C.H. Robinson
CHRW
$24.3B
$4M 2.04%
42,676
-330
-0.8% -$30.4K
XOM icon
17
ExxonMobil
XOM
$615B
$3.92M 2%
52,606
+4,280
+9% +$342K
MCD icon
18
McDonald's
MCD
$190B
$3.86M 1.96%
24,662
+130
+0.5% +$21.4K
PEP icon
19
PepsiCo
PEP
$185B
$3.74M 1.9%
34,253
+135
+0.4% +$15.4K
LH icon
20
Labcorp
LH
$23.1B
$3.62M 1.85%
26,086
-35
-0.1% -$5.14K
IWM icon
21
iShares Russell 2000 ETF
IWM
$81.2B
$3.59M 1.83%
23,654
-180
-0.8% -$27.8K
ABT icon
22
Abbott
ABT
$177B
$3.54M 1.8%
59,092
+590
+1% +$35.5K
KO icon
23
Coca-Cola
KO
$353B
$3.52M 1.8%
81,134
-55
-0.1% -$2.47K
RTX icon
24
RTX Corp
RTX
$262B
$3.42M 1.74%
43,227
+55
+0.1% +$4.54K
CL icon
25
Colgate-Palmolive
CL
$73.6B
$3.36M 1.71%
46,928
+990
+2% +$71.2K
1
2 3 4

Similar funds

SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
RAG
RIA Advisory Group Des Moines, Iowa $421M AUM 30.78% 1-Year Est. Return
TFP
Triune Financial Partners Overland Park, Kansas $421M AUM 22.09% 1-Year Est. Return
AFA
AllGen Financial Advisors Orlando, Florida $421M AUM 14.16% 1-Year Est. Return
CWM
Cordatus Wealth Management Newtown, Pennsylvania $420M AUM 24.63% 1-Year Est. Return
MG
MilWealth Group Milwaukee, Wisconsin $420M AUM 12.37% 1-Year Est. Return
HWMG
Hurlow Wealth Management Group Bloomington, Indiana $420M AUM 16.85% 1-Year Est. Return
AI
ArchPoint Investors Coral Gables, Florida $420M AUM 42.19% 1-Year Est. Return

Boston Research & Management's Q1 2018 Portfolio in Review

As of Q1 2018, Boston Research & Management held 97 positions worth $196M, down 1.6% from $199M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Trading was light in Q1 2018: portfolio turnover was 2.1%. Boston Research & Management opened no new positions and exited 2, leaving the 97-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Industrials and Healthcare.

  • Boston Research & Management added most to Merck in Q1 2018, an estimated $2.12M increase.
  • Boston Research & Management's biggest Q1 2018 reduction was Wells Fargo, cutting an estimated $2.87M.
  • Boston Research & Management fully exited Union Pacific in Q1 2018, selling an estimated $351K.
  • Boston Research & Management's ten largest holdings make up 25% of its $196M portfolio in Q1 2018.
  • Boston Research & Management opened 0 new positions and closed 2 in Q1 2018.
  • Boston Research & Management's portfolio value fell 1.6% quarter-over-quarter to $196M.

Based on Boston Research & Management's 13F filing for Q1 2018, filed 9 May 2018.